4th Quarter - Report

CROSSROADS STRATEGIES, LLC for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

General education about policies to improve outcomes for patients with APOL-1 kidney disease.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
BRITTANY JOHNSON HERNANDEZ —
CHERYL LYNN JAEGER —
MATHEW LAPINSKI —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
BRITTANY JOHNSON HERNANDEZ —
CHERYL LYNN JAEGER —
MATHEW LAPINSKI —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
BRITTANY JOHNSON HERNANDEZ —
CHERYL LYNN JAEGER —
MATHEW LAPINSKI —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.